In Unstable Angina or Non–ST-Segment Acute Coronary Syndrome, Should Patients With Multivessel Coronary Artery Disease Undergo Multivessel or Culprit-Only Stenting?
Mehdi H. Shishehbor, DO, MPH*,
Michael S. Lauer, MD, FACC*,
Inder M. Singh, MD, MS ,
Derek P. Chew, MBBS, MPH ,
Juhana Karha, MD*,
Sorin J. Brener, MD, FACC*,
David J. Moliterno, MD, FACC ,
Stephen G. Ellis, MD, FACC*,
Eric J. Topol, MD, FACC|| and
Deepak L. Bhatt, MD, FACC*,*
* Departments of *Cardiovascular Medicine
Internal Medicine, Cleveland Clinic, Cleveland, Ohio
Department of Cardiology, Flinders Medical Center, South Australia, Australia
Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky
|| Department of Genetics, Case Western Reserve University, Cleveland, Ohio
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Kaplan-Meier Curves for Patients Undergoing Multivessel Versus Culprit-Only Stenting
(A) Kaplan-Meier curves for the composite end point of death, myocardial infarction (MI), or revascularization for patients undergoing multivessel versus culprit-only stenting (n = 1,240). (B) Kaplan-Meier curves for the composite end point of death or MI for patients undergoing multivessel versus culprit-only stenting (n = 1,240). (C) Kaplan-Meier mortality curves for patients undergoing multivessel versus culprit-only stenting (n = 1,240). (D) Kaplan-Meier curves for revascularization for patients undergoing multivessel versus culprit-only stenting (n = 1,240).
|
|
View larger version (21K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Kaplan-Meier Curves for Propensity-Matched Patients Undergoing Multivessel Versus Culprit-Only Stenting
(A) Kaplan-Meier curves for the composite end point of death, myocardial infarction (MI), or revascularization for propensity-matched patients undergoing multivessel versus culprit-only stenting (n = 630). (B) Kaplan-Meier curves for the composite end point of death or MI for propensity-matched patients undergoing multivessel versus culprit-only stenting (n = 630). (C) Kaplan-Meier mortality curves for propensity-matched patients undergoing multivessel versus culprit-only stenting (n = 630). (D) Kaplan-Meier curves for revascularization for propensity-matched patients undergoing multivessel versus culprit-only stenting (n = 630).
|
|
|
